Dergiler / Electrica / 2018 / Cilt: 18 - Sayı: 2

Cloning of Presenilin 2 cDNA and Construction of Vectors Carrying Effective Mutations in the Pathogenesis of Familial Alzheimer's Disease

Sayfa
310–320
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In future studies, it will be determined if there is an increase in Aβ42 protein levels, and the effect on this early onset AD can be identified.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Alzheimer's disease (AD) is a neurodegenerative disease and is identified by the detection of amyloid-plaques and neurofibrillary tangles in the brain.
📊
Temel Bulgular & Veri:Amyloid precursor protein gene, presenilin 1 (PSEN1) gene, and presenilin 2 (PSEN2) gene are responsible for this disease.
💡
Sonuç & Katkı:In future studies, it will be determined if there is an increase in Aβ42 protein levels, and the effect on this early onset AD can be identified.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Alzheimer's disease (AD) is a neurodegenerative disease and is identified by the detection of amyloid-plaques and neurofibrillary tangles in the brain. Amyloid precursor protein gene, presenilin 1 (PSEN1) gene, and presenilin 2 (PSEN2) gene are responsible for this disease. PSEN2 and amyloid precursor protein (APP) gene mutations are a much rarer cause of familial AD patients. This study aims to clone the PSEN2 gene and create vectors with different mutations by directed mutagenesis. As a result of the experiments, the PSEN2 cDNA was cloned between the BamHI and KpnI cut-off points of the pBluescript II sk (+) vector. PSEN1 and PSEN2 homologs have a role in cell destiny decision and AD progress. We studied some of the PSEN2 mutations (Ala252Thr and Pro334Arg) and provided expression analysis in eukaryotic cell cultures. Amyloid β-protein (Aβ), which is produced by endoproteolytic cleavage of the APP, is considered to play a role in AD. While nominal concentration of Aβ40 is 10 times of Aβ42, the last peptide is firmly linked to AD pathogenesis. Amyloid β-protein is generated by the γ-secretase cleavage of APP onset and the progression of AD, and it is the primary ingredient of the senile plaques. The Aβ42 dodecamer plays a central role in AD. In future studies, it will be determined if there is an increase in Aβ42 protein levels, and the effect on this early onset AD can be identified.

🔖

Bu Makaleye Atıf Yap

ÖZTAN, G., YOKEŞ, B., İŞSEVER, H. (2018). Cloning of Presenilin 2 cDNA and Construction of Vectors Carrying Effective Mutations in the Pathogenesis of Familial Alzheimer's Disease. Electrica, Cilt: 18 - Sayı: 2, 310–320. https://ajindex.com/articles/153720

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. A Kumar, S. A. Ekavali, “A review on Alzheimer’s disease pathophysiology and its management: an update”, Pharmacol Rep, vol. 67, no. 2, pp. 195-203, 2015.
  2. J. Guo, J. Cheng, B. J. North, W. Wei, “Functional analyses of major cancer-related signaling pathways in Alzheimer’s disease etiology”, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1868, no. 2, pp. 341-358, 2017.
  3. P. A. Defina, R. S. Moser, M. Glenn, J. D. Lichtenstein, J Fellus, “Alzheimer’s Disease Clinical and Research Update for Health Care Practitioners”, J Aging Res, 2013.
  4. S. Parvathy, D. J. Buxbaum, “Molecular Genetics of Alzheimer Disease”, Neuropsychopharmacology: The Fifth Generation of Progress, pp. 1199-1213, 2002.
  5. L. Crews, E. Masliah, “Molecular mechanisms of neurodegeneration in Alzheimer’s disease”, Human Molecular Genetics, vol. 19, no. R1, pp. 12-20, 2010. M. B. Yokes, “Molecular genetics of Alzheimer’s Disease”, J Cell Mol Biol, vol. 6, no. 2, pp. 73-97, 2007.
  6. P. H. St George-Hyslop, A. Petit, “Molecular biology and genetics of Alzheimer’s disease”, Comptes Rendus Biologies, vol. 328, no. 2, pp. 119-130, 2004. M. Plečkaitytė, “Alzheimer’s disease: a molecular mechanism, new hypotheses, and therapeutic strategies”, Medicina, vol. 46, no. 1, 2010.
  7. P. H. St George-Hyslop. “Molecular Genetics of Alzheimer’s Disease”, Biol Psychiatry, vol. 47, no. 3, pp. 183-199, 2000.
  8. Y. Cai, S. S. An, S. Kim, “Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementiaassociated disorders”, Clin Interv Aging, vol. 10, pp. 1163-1172, 2015.
  9. G. D. Schellenberg, T. D. Bird, E. M. Wijsman, H. T. Orr, L. Anderson, E. Nemens, J. A. White, L. Bonnycastle, J. L. Weber, M. E. Alonso, H. Potter, L. L. Heston, G. M. Martin, “Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14”, Science, vol. 258, pp. 668-671, 1992.
  10. D. Campion, J. M. Flaman, A. Brice, D. Hannequin, C. Martin, V. Moreau, F. Charbonnier, O. Didierjean, S. Tardieu, C. Penet, M. Puel, F. Pasquier, F. Le Doze, G. Bellis, A. Calenda, R. Heilig, M. Martinez, J. Mallet, M. Bellis, F. C. Darpoux, Y. Agid, T. Frebourg, “Mutations of the presenilin I gene in families with early-onset Alzheimer’s disease”, Hum Mol Genet, vol. 4, no. 12, pp. 373- 377, 1995.
  11. R. F. Clark, M. Cruts, K. M. Korenblat, C. He, C. Talbot, C. Van Broeckhoven, A. M. Goate, “A yeast artificial chromosome contig from human chromosome 14q24 spanning the Alzheimer’s disease locus AD3”, Hum Mol Genet, vol. 4, no. 8, pp.